Latest filing published 17 Feb 2012 for Sagent Pharmaceuticals, Inc., €5,103.
Insider track record
No signal scores available.
China Renaissance Capital Investment II GP: trading record in brief
China Renaissance Capital Investment II GP appears in our data through filings on Sagent Pharmaceuticals, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 26 April 2011 to 17 February 2012, the count stands at 25 filings.
Every open-market trade on record is a sale: 22 sales worth €7.0M. Outside the open market, there are 2 share grants. In 2012 alone, the filings show no purchases and 18 sales.
The newest entry dates from 17 February 2012: an open-market sale of €5,103, in Sagent Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. US insiders must file a Form 4 within two business days of a trade. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to China Renaissance Capital Investment II GP
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 300 shares@ US$22.34Common StockSEC:0001209191-12-011254:0
- 10,000 shares@ US$21.93Common StockSEC:0001209191-12-011254:1
- 76,700 shares@ US$22.07Common StockSEC:0001209191-12-011254:2
- 12,837 shares@ US$22.30Common StockSEC:0001209191-12-007875:0
- 13,514 shares@ US$22.31Common StockSEC:0001209191-12-007875:1
- 10,000 shares@ US$22.79Common StockSEC:0001209191-12-007875:2
- 1,702 shares@ US$22.13Common StockSEC:0001209191-12-006708:0
- 3,398 shares@ US$22.19Common StockSEC:0001209191-12-006708:1
- 45,000 shares@ US$22.27Common StockSEC:0001209191-12-006708:2
- 15,000 shares@ US$22.53Common StockSEC:0001209191-12-005846:0
- 4,838 shares@ US$22.46Common StockSEC:0001209191-12-005846:1
- 5,538 shares@ US$22.43Common StockSEC:0001209191-12-005846:2
- 19,844 shares@ US$22.16Common StockSEC:0001209191-12-005158:0
- 3,041 shares@ US$21.95Common StockSEC:0001209191-12-004478:0
- 24,900 shares@ US$21.91Common StockSEC:0001209191-12-004478:1
- 18,000 shares@ US$21.86Common StockSEC:0001209191-12-004478:2
- 8,700 shares@ US$21.91Common StockSEC:0001209191-12-003628:0
- 87,385 shares@ US$21.89Common StockSEC:0001209191-12-003628:1
- 8,910 shares@ US$22.07Common StockSEC:0001209191-11-062984:0
- 700 shares@ US$22.01Common StockSEC:0001209191-11-062984:1
- 14,807 shares@ US$21.92Common StockSEC:0001209191-11-062984:2
- 24,386 shares@ US$25.21Common StockSEC:0001209191-11-057025:0
- 142,000 shares@ US$0.01Common StockSEC:0001209191-11-024717:0
- 312,500 shares@ US$16.00Common StockSEC:0001209191-11-024717:1
- 2,734,000 sharesCommon StockSEC:0001209191-11-024717:2
25 of 25 declarations
